ALX Oncology Holdings Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€163.88K - Gross profit
-€163.88K - SG&A expenses
€22.79M - R&D expenses
€78.86M - EBITDA
-€100.41M - D&A
€720.72K - EBIT
-€104.37M - Interest expenses
€1.44M - EBT
-€100.02M - Tax expenses
€0.00 - Net income
-€100.02M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€2.31M - Changes in working capital
-€10.82M - Operating cash flow
-€90.51M - Capex
€271.13K - Other investing cash flow
€0.00 - Net investing cash flow
€93.38M - Total cash dividends paid
€0.00 - Issuance of common stock
-€25.08M - Debt repayment
-€839.12K - Other financing cash flow
€25.95M - Net financing cash flow
€362.08K - Foreign exchange effects
€0.00 - Net change in cash
€3.23M - Cash at end of period
€16.62M - Free cash flow
-€90.24M
Balance sheet
- Cash and cash equivalents
€16.56M - Cash and short-term investments
€68.05M - Total receivables
€571.43K - Inventory
€0.00 - Other current assets
€4.53M - Total current assets
€73.15M - Property, plant & equipment
€1.28M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€3.63M - Other non-current assets
€3.72M - Total non-current assets
€8.63M - Total assets
€81.78M - Accounts payable
€4.21M - Short-term debt
€4.33M - Other current liabilities
€7.63M - Total current liabilities
€16.17M - Long-term debt
€9.55M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€793.65K - Total non-current liabilities
€10.34M - Total liabilities
€26.52M - Common stock
€46.33K - Retained earnings
-€581.57M - Other equity
€30.89K - Total equity
€55.27M - Total liabilities and shareholders' equity
€81.78M
Company information
- Market capitalization
€18.50M - Employees
65 - Enterprise Value
€11.01M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-181.0% Much worse than peer group: -48.5% - ROA
-
-122.3% Worse than peer group: -112.9% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-490.8% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.54M